Major Depression Clinical Trial
Official title:
Attachment Security as Mediator and Moderator of Outcome in Major Depression Following Interpersonal Therapy and Cognitive Behavior Therapy
In this study, the focus is on an individual's attachment security and its relation to treatment outcome in Major Depression.Adult attachment reflects how one seeks psychological and physical proximity to others for security and protection in times of stress. Researchers typically define four types of attachment security: one secure and three insecure (preoccupied, dismissing, and fearful). Adults with Major Depressive Disorder (MDD) will be randomly assigned to either Interpersonal Psychotherapy (IPT) or to Cognitive Behavior Therapy (CBT). The expectation is that adults with avoidant attachment styles will respond better to CBT, and adults with preoccupied attachment styles will respond better to IPT. Also, in comparison to CBT, outcome in IPT is hypothesized to be more closely related to change in attachment.
At the current rate of increase, Major Depression, it will be the 2nd most disabling
condition in the world by 2020, behind heart disease. There are now a number of effective
treatments for depression. However, a significant number of people either partially recover
from their depression after a course of treatment, or do not recover at all. For example,
between 30% and 50% of depressed individuals taking an antidepressant are partially or
totally resistant to the treatment, and more than ½ of patients in psychotherapy never
achieve full remission. The goal of treatment of major depression should always be full
remission. Not achieving full remission from depression is problematic as lingering symptoms
are a powerful predictor of relapse.
One problem may be in the type of treatment that is offered to the individual. We know
little about which clients benefit from which type of treatments and which clients do
poorly. One individual may respond better to one type of treatment, while another individual
may respond better to another type of treatment. The accurate identification of how an
individual's characteristics interact with the type of treatment offered will help us match
patients to the best-suited treatment for them, so we can optimize outcome.
One characteristic that may be related to treatment outcome is adult attachment security.
Adult attachment reflects how one seeks psychological and physical proximity to others for
security and protection in times of stress. Researchers typically define four types of
attachment security: one secure and three insecure (preoccupied, dismissing, and fearful).
Secure adults have a good sense of self-worth and are comfortable with intimacy. Preoccupied
adults have an exaggerated desire for closeness and a heightened concern about rejection.
Dismissing adults deny the value of close relationships and instead value self-reliance.
Finally, fearful adults have a very negative sense of self and avoid intimacy because they
fear rejection. Secure attachment has been linked to positive interpersonal relationships
and psychological health and insecure attachment has been linked to overall psychological
distress.
In this study, I focus on attachment security and its relation to treatment outcome. Adults
with Major Depressive Disorder (MDD) will be randomly assigned to either Interpersonal
Psychotherapy (IPT) or to Cognitive Behavior Therapy (CBT). The expectation is that adults
with avoidant attachment styles will respond better to CBT, and adults with preoccupied
attachment styles will respond better to IPT. Also, in comparison to CBT, outcome in IPT is
hypothesized to be more closely related to change in attachment.
The power of this study lies in its considered integration of three important issues at the
forefront of mental health today: MDD, attachment, and treatment. MDD is a leading cause of
disability worldwide and theoretically and empirically related to attachment. Attachment
theory is a primary paradigm in the developmental, social/personality, and clinical
literatures, and forms the theoretical cornerstone for IPT. IPT and CBT, while successful to
a degree, fail or partially fail in many cases. Successful outcome in IPT depends on
successfully improving a patient's attachment representations; this is not the case in CBT
where change in depression is associated with change in cognition. The fact that these
treatments represent contrasting approaches in the context of attachment, affords us a
unique opportunity to investigate the relationships between attachment and treatment outcome
for two distinct treatments, and investigate whether an individual's attachment security
interacts with the type of treatment offered to yield a better response for one type of
treatment versus another. This research could have a major impact on tailoring treatment to
patient characteristics to optimize treatment for major depression.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03062150 -
Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression
|
N/A | |
Completed |
NCT04352101 -
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
|
Phase 4 | |
Completed |
NCT02855918 -
Blood Biomarkers in Suicidal Behaviour
|
N/A | |
Recruiting |
NCT03039387 -
Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients
|
N/A | |
Recruiting |
NCT02213016 -
Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients
|
Phase 4 | |
Completed |
NCT01636791 -
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
|
Phase 3 | |
Completed |
NCT01683539 -
Understanding How Cognitive Remediation Works
|
N/A | |
Recruiting |
NCT02237937 -
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
|
Phase 4 | |
Completed |
NCT01201148 -
Open Pilot Trial of TES for Depression
|
Phase 2 | |
Completed |
NCT00953108 -
Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients
|
Phase 3 | |
Terminated |
NCT01244711 -
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
|
Phase 4 | |
Completed |
NCT00806143 -
Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression
|
Phase 4 | |
Terminated |
NCT00695552 -
The Effect of Exercise on Depressive Symptoms in Unmedicated Patients
|
N/A | |
Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
Completed |
NCT00482482 -
Yoga in Unipolar and Bipolar Disorders
|
N/A | |
Completed |
NCT00532480 -
Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine
|
Phase 4 | |
Completed |
NCT00466323 -
The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.
|
N/A | |
Completed |
NCT00616759 -
The Effect on Cognition of Terminating ECT Induced Seizures With Propofol
|
N/A | |
Recruiting |
NCT00209807 -
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
|
Phase 4 | |
Completed |
NCT00167310 -
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
|
Phase 2 |